.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Accenture
Fuji
US Army
UBS
Novartis
Mallinckrodt
Federal Trade Commission
Julphar
McKesson

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,045,302

« Back to Dashboard

Summary for Patent: 5,045,302

Title: Ligands and cationic complexes thereof with technetium-99m
Abstract:This invention concerns novel bidentate ligands L having two phosphorus or arsenic atoms. Cationic complexes of the ligands with Technetium-99m, e.g. having the formula [TcO.sub.2 L.sub.2 ].sup.+, are useful for body imaging, particularly myocardial imaging. The ligands have the general formula where Q is phosphorus or Z is a --CC-- or --CCC-- or --COC-- groups, the four groups Y are all C1-C8 saturated hydrocarbon or fluorohydrocarbon with 1-3 ether oxygen atoms.
Inventor(s): Kelly; James D. (Amersham, GB2), Chiu; Kwok W. (Gloucester, GB2), Latham; Ian A. (West Bridgford, GB2)
Assignee: Amersham International plc (Buckinghamshire, GB2)
Application Number:07/329,639
Patent Claim Types:
see list of patent claims
Compound;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,045,302

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8808414Apr 11, 1988

International Patent Family for Patent: 5,045,302

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria133956► Subscribe
Canada1336437► Subscribe
China1022633► Subscribe
China1024013► Subscribe
China1031828► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Johnson and Johnson
Daiichi Sankyo
Deloitte
Argus Health
Covington
US Army
Queensland Health
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot